Skip to content

A study to evaluate the efficacy and safety of applying a serum containing hydroxypinacolone retinoate and retinol in glycospheres in combination with a sunscreen containing polypodium leucotomos for the treatment of melasma in Asians

A study to evaluate the efficacy and safety of applying a serum containing hydroxypinacolone retinoate and retinol in glycospheres in combination with a sunscreen containing polypodium leucotomos for the treatment of melasma in Asians

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250210003
Enrollment
30
Registered
2025-02-10
Start date
2024-01-29
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

melasma melasma, hydroxypinacolone retinoate, retinol

Interventions

Patients were treated with serum containing hydroxypinacolone retinoate and retinol in glycospheres in combination with a sunscreen containing polypodium leucotomos for 2 months. Then, participants w
Experimental Drug
serum containing hydroxypinacolone retinoate and retinol in glycospheres in combination with a sunscreen containing polypodium leucotomos

Sponsors

Faculty of Medicine Siriraj hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Asians aged 18 and above 2. Fitzpatrick Skin Type III-V 3. Diagnosed with melasma 4. Presence of melasma on both sides of the face

Exclusion criteria

Exclusion criteria: 1. Pregnant or breastfeeding individuals 2. facial dermatitis 3. recent hormonal or contraceptive use (within 3 months) 4. recent facial laser treatments (within 6 months) 5. recent melasma treatments (topical or oral within 3 months) 6. recent skin whitening agent use (within 1 month) 7. allergy to retinoids 8. oral antioxidant use 9. diagnosed abnormal mental conditions, and refusal to consent for photography

Design outcomes

Primary

MeasureTime frame
mMASI scores (modified Melasma Area Severity Index) Baseline, 1, 2, 3 months after using serum Physician,melanin index Baseline, 1, 2, 3 months after using serum Mexameter,erythema index Baseline, 1, 2, 3 months after using serum mexameter

Secondary

MeasureTime frame
skin firmness Baseline, 1, 2, 3 months after using serum cutometer,hydration Baseline, 1, 2, 3 months after using serum corneometer,Transepidermal water loss Baseline, 1, 2, 3 months after using serum Tewarmeter,Safety Baseline, 1, 2, 3 months after using serum Adverse events

Countries

Thailand

Contacts

Public ContactRungsima Wanitphakdeedecha

Faculty of Medicine Siriraj Hospital, Mahidol University

rungsima.wan@mahidol.ac.th024197000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026